Screener
Bristol-Myers Squibb BMY Net product sales — Total Revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net product sales | $12,588 | $11,909 | $23,756 | $22,794 |
| Alliance and other revenues | 385 | 360 | 706 | 676 |
| Total Revenues | 12,973 | 12,269 | 24,462 | 23,470 |
| Cost of products sold(a) | 3,726 | 3,372 | 7,146 | 6,404 |
| Selling, general and administrative | 1,826 | 1,713 | 3,443 | 3,297 |
| Research and development | 2,959 | 2,580 | 5,608 | 4,837 |
| Acquired IPRD | — | 1,508 | 94 | 1,695 |
| Amortization of acquired intangible assets | 437 | 830 | 874 | 1,660 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Bristol-Myers Squibb's net product sales — total revenues?
- Bristol-Myers Squibb (BMY) reported net product sales — total revenues of $12.59B in Q2 2026.
- How has Bristol-Myers Squibb's net product sales — total revenues changed year-over-year?
- Bristol-Myers Squibb's net product sales — total revenues increased by 5.7% year-over-year, from $11.91B to $12.59B.
- What is the long-term trend for Bristol-Myers Squibb's net product sales — total revenues?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's net product sales — total revenues has grown at a 0.9% compound annual growth rate (CAGR), from $45.06B to $46.76B.
- What does net product sales — total revenues mean?
- This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, rebates, and discounts. It serves as the primary indicator of the company's commercial performance and market demand for its therapeutic portfolio. By focusing on product-specific revenue, it highlights the core operational success of the firm's drug development and marketing efforts.
Ask your AI about Bristol-Myers Squibb's net product sales — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude